Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15130)	2/16/1998 8:13:00 PM
From: Machaon	Read Replies (2) \| Respond to of 32384

<< Where Your Visitors Came From >> I was disappointed to see that neither Iran, Iraq or Algeria had hits to your website. In fact, Cuba and North Korea are showing absolutely no interest, either. I wonder if that is a bad sign? It is interesting to see how many different countries are hitting it. You had 25 "known" hits from a small country like the Netherlands. Henry, how do you rate LGND's cancer program versus the competition? Do you consider LGND in first place in the race towards a "better" cure? If yes, who would you consider to be in second place? I am just wondering about the situation where Targretin is a blockbuster hit, but some other biotech is also in position to come out with a product of similar success. Thanks, Bob

To: Henry Niman who wrote (15130)	2/17/1998 3:17:00 AM
From: Alper H.YUKSEL	Read Replies (1) \| Respond to of 32384

Henry, I believe that the list of countries for hits on your website is not complete. For example, I know of myself and couple of other people here in Turkey, having visited your site. I'm not a technical expert but this could be because of our ISP provider, which has a US domain name, and which gives us e-mail addresses without the usual country extension 'tr'. In that case, I would expect our hits to be included under US Network. Alper